Resonac Holdings Corporation
Stock Price Chart
2026/01/16 UpdatedPrice Trend
2026/01/16 UpdatedPrice & Trading Details
2026/01/16 UpdatedPRICE
TRADING
Analyst Recommendations 11 analysts
Updated 2026/01/11Shareholder Composition
Updated 2026/01/11Major Holders
Updated 2026/01/11| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
SmallCap World Fund Inc
|
8.6M | +47.37% | |
|
MFS SERIES TRUST X-MFS International Growth Fund
|
4.7M | +4.34% | |
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
2.6M | +0.28% | |
|
NEW ECONOMY FUND
|
2.2M | 0.00% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
1.7M | +3.09% | |
|
iShares Trust-iShares Core MSCI EAFE ETF
|
1.2M | +0.86% |
Dividend History
Updated 2026/01/11| Year | Dividend | Change |
|---|---|---|
| 2025 | ¥65 | 0.0% |
| 2024 | ¥65 | 0.0% |
| 2023 | ¥65 | 0.0% |
| 2022 | ¥65 | 0.0% |
| 2021 | ¥65 | - |
Financial Performance
2026/01/11 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥1,419,635M | ¥1,392,621M | ¥1,295,395M | ¥1,391,480M |
| Gross Profit | ¥337,994M | ¥304,847M | ¥228,573M | ¥311,099M |
| Operating Income | ¥87,198M | ¥61,727M | -¥9,407M | ¥89,036M |
| Pretax Income | ¥32,932M | ¥66,689M | ¥651M | ¥100,589M |
| Net Income | -¥12,094M | ¥32,422M | -¥6,505M | ¥73,503M |
| EPS | -¥77.40 | ¥179.02 | -¥35.91 | ¥406.61 |
| Operating Margin | 6.14% | 4.43% | -0.73% | 6.40% |
| Balance Sheet | ||||
| Total Assets | ¥2,142,390M | ¥2,111,192M | ¥2,054,594M | ¥2,172,626M |
| Total Equity | ¥513,989M | ¥539,807M | ¥560,129M | ¥664,616M |
| Total Liabilities | ¥1,628,401M | ¥1,571,385M | ¥1,494,465M | ¥1,508,010M |
| Cash | ¥236,237M | ¥188,700M | ¥190,642M | ¥294,656M |
| Interest-bearing Debt | ¥830,756M | ¥1,075,371M | ¥1,030,145M | ¥1,023,706M |
| Equity Ratio | 23.99% | 25.57% | 27.26% | 30.59% |
| D/E Ratio | 1.62 | 1.99 | 1.84 | 1.54 |
| Cash Flow | ||||
| Operating CF | ¥115,283M | ¥99,376M | ¥118,715M | ¥163,653M |
| Investing CF | ¥28,606M | -¥54,667M | -¥55,158M | -¥52,306M |
| Financing CF | -¥121,741M | -¥103,267M | -¥73,086M | -¥20,468M |
| Free CF | ¥47,542M | ¥11,519M | ¥33,156M | ¥75,341M |
| Efficiency | ||||
| ROE | -2.35% | 6.01% | -1.16% | 11.06% |
| ROA | -0.56% | 1.54% | -0.32% | 3.38% |
Latest IR Information
-
No IR information found for this company.
Searched stock code: 4004
Latest News (5 items)
-
Average Analyst Rating: none
Average Target Price: ¥6,659
Rating Score: - (Based on 11 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Resonac Holdings Corporation operates as a chemical company in Japan, China, rest of Asia, and internationally. It operates through Semiconductor and Electronic Materials, Mobility, Innovation Enabling Materials, and Chemicals segments. The company offers gases and solvents, abatement systems and surface treatments, CMP slurries, and anti-charging materials; semiconductor-related materials, display and sensor-related materials, and films; base and photosensitive materials for PWBs; hard disks, SiCs, and optical semiconductors for use as electronic device components; and molded plastics/sheet-formed, powder metal, and aluminum products for automotives. It provides lithium-ion batteries and mechanical carbon; ceramics, resins, cosmetic ingredients/medicinal additives, monomers, adhesives, tapes, and chromatography products; and elastomers. In addition, the company offers polyimides; HD media; friction materials; aluminum gravity casting products; packaging/containers for food, medicine, and electronics; electrical insulating epoxy resin molded products; zipper bags and tapes; titanium oxide and alumina; and elastic polishing grindstone. Further, it provides polypropylene and polyethylene; liquefied carbon dioxide, dry ice, and gas-related equipment; liquefied oxygen, nitrogen, and argon; molecular sieve; graphite electrodes; plasters, fireproofing pipes, and wall sidings; cement and moisture removal sheets; industrial materials; and FRP, coated sand, and separating mediums. Additionally, the company engages in the contract development and manufacturing of regenerative medicines; leasing of personal computers and other business equipment; outsourcing of salary, welfare, and finance-related business; and synthesis, analysis, and SDS preparation services. The company was formerly known as Showa Denko K.K. and changed its name to Resonac Holdings Corporation in January 2023. The company was incorporated in 1939 and is headquartered in Tokyo, Japan.